Functional Diversities of Regulatory T Cells in the Context of Cancer Immunotherapy
Regulatory T cells (Tregs) are a subset of CD4+ T cells with their immunosuppressive activities to block abnormal or excessive immune responses to self and non-autoantigens. Tregs express the transcription factor Foxp3, maintain the immune homeostasis, and prevent the initiation of anti-tumor immune...
Main Authors: | Gao, R. (Author), Shi, G.-P (Author), Wang, J. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
Editorial: Novel Strategies for Cancer Immunotherapy: Targeting Immune-Mediated Suppressive Mechanisms
by: Virginie Lafont, et al.
Published: (2021-05-01) -
Therapy with CD4+CD25+ T regulatory cells – should we be afraid of cancer?
by: Mateusz Gliwiński, et al.
Published: (2019-04-01) -
Revising PTEN in the Era of Immunotherapy: New Perspectives for an Old Story
by: Geny Piro, et al.
Published: (2019-10-01) -
REGULATORY T–CELLS: ORIGIN AND FUNCTION
by: I. S. Freidlin
Published: (2014-07-01) -
Armored CAR T-Cells: The Next Chapter in T-Cell Cancer Immunotherapy
by: Hawkins ER, et al.
Published: (2021-04-01)